{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:31Z","timestamp":1792723111843,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2026ZD1807500"],"award-info":[{"award-number":["2026ZD1807500"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025QC813"],"award-info":[{"award-number":["ZR2025QC813"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021ZD0200900"],"award-info":[{"award-number":["2021ZD0200900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82602976"],"award-info":[{"award-number":["82602976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01087","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:08:06Z","timestamp":1790413686000},"page":"e01087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery"],"prefix":"10.1016","volume":"23","author":[{"given":"Peng","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01087_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01087_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2026.111752","article-title":"Precision pharmacology of CNS GPCRs: from biased signaling to translational therapeutics","volume":"147","author":"Gujjula","year":"2026","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neurot.2026.e01087_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41386-026-02388-0","article-title":"Dopaminergic modulation of pancreatic beta-cell insulin secretion and implications for antipsychotic-induced glucose dysregulation: a systematic review and meta-analysis","volume":"51","author":"Al-Hasani","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurot.2026.e01087_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14010035","article-title":"From monoamines to systems psychiatry: rewiring depression science and care (1960s-2025)","volume":"14","author":"Tanaka","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2026.e01087_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic Pain--Misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2026.e01087_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/life12091433","article-title":"New paradigms in pharmaceutical development","volume":"12","author":"Cacabelos","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.neurot.2026.e01087_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurot.2026.e01087_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-pharmtox-061724-080727","article-title":"G protein-coupled receptor heteromers in brain: functional and therapeutic importance in neuropsychiatric disorders","volume":"65","author":"Sun","year":"2025","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neurot.2026.e01087_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4103\/1673-5374.189168","article-title":"Volume transmission and receptor-receptor interactions in heteroreceptor complexes: understanding the role of new concepts for brain communication","volume":"11","author":"Fuxe","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neurot.2026.e01087_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041719","article-title":"Allosteric interactions between adenosine A(2A) and dopamine D(2) receptors in heteromeric complexes: biochemical and pharmacological characteristics, and opportunities for PET imaging","volume":"22","author":"Prasad","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nchembio0309-131","article-title":"Building a new conceptual framework for receptor heteromers","volume":"5","author":"Ferr\u00e9","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neurot.2026.e01087_bib12","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1507704112","article-title":"Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer","volume":"112","author":"Bonaventura","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e01087_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.tips.2018.10.007","article-title":"A2AR-D2R heteroreceptor complexes in cocaine reward and addiction","volume":"39","author":"Borroto-Escuela","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib14","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1007\/s12035-018-0887-1","article-title":"Disruption of A2AR-D2R heteroreceptor complexes after A2AR transmembrane 5 peptide administration enhances cocaine self-administration in rats","volume":"55","author":"Borroto-Escuela","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01087_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2026.e01087_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab0467","article-title":"Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia","volume":"9","author":"Moreno","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.neurot.2026.e01087_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2026.e01087_bib18","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","article-title":"Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A\u00b7mGlu2) receptor heteromerization and its psychoactive behavioral function","volume":"287","author":"Moreno","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2026.e01087_bib19","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.neuropharm.2012.01.010","article-title":"Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades","volume":"62","author":"Delille","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2026.e01087_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuropharm.2013.02.005","article-title":"The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - relevance of receptor heterocomplexes and interaction through functional brain pathways","volume":"70","author":"Delille","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2026.e01087_bib21","doi-asserted-by":"crossref","first-page":"21377","DOI":"10.1073\/pnas.0903676106","article-title":"Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth","volume":"106","author":"Hasbi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e01087_bib22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI126361","article-title":"D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease","volume":"130","author":"Sebastianutto","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neurot.2026.e01087_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2013.11.104","article-title":"Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes","volume":"443","author":"Borroto-Escuela","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2026.e01087_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuropharm.2011.05.023","article-title":"Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors","volume":"61","author":"Albizu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2026.e01087_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1471-4159.2009.06078.x","article-title":"Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells","volume":"109","author":"Cabello","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e01087_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib27","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.1008911107","article-title":"Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine","volume":"107","author":"Navarro","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e01087_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061245","article-title":"Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers","volume":"8","author":"Navarro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01087_bib29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bph.16003","article-title":"The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors","volume":"180","author":"Ruiz-Cantero","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01087_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.105937","article-title":"Sigma-1 receptor activation produces faster antidepressant-like effect through enhancement of hippocampal neuroplasticity: focus on sigma-1-5-HT1A heteroreceptor complex","volume":"184","author":"Ren","year":"2025","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurot.2026.e01087_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12035-025-05568-z","article-title":"Presence of astrocytic S1R\/5-HT1A heterocomplex in the mPFC: a putative link to S1R activation mediated faster antidepressant-like effects","volume":"63","author":"Ren","year":"2025","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01087_bib32","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","article-title":"NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus","volume":"34","author":"Pabba","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e01087_bib33","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1111\/bph.70598","article-title":"Activation of sigma non-opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive-like behaviours in mice","volume":"183","author":"Wang","year":"2026","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01087_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.tips.2019.07.006","article-title":"The molecular function of \u03c3 receptors: past, present, and future","volume":"40","author":"Schmidt","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awq367","article-title":"The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke","volume":"134","author":"Ruscher","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e01087_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00774","article-title":"Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction","volume":"23","author":"Sa\u0142aciak","year":"2026","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e01087_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbi.2024.06.008","article-title":"Astrocyte-specific activation of sigma-1 receptors in mPFC mediates the faster onset antidepressant effect by inhibiting NF-\u03baB-induced neuroinflammation","volume":"120","author":"Wang","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2026.e01087_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70490","article-title":"Targeting neuroinflammation in depression: the integrative role of Sigma-1 receptor modulation","volume":"170","author":"Wang","year":"2026","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e01087_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jphs.2015.01.001","article-title":"Role of the 5-HT1A autoreceptor in the enhancement of fluvoxamine-induced increases in prefrontal dopamine release by adrenalectomy\/castration in mice","volume":"127","author":"Hasebe","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2017.05.035","article-title":"Psychopharmacology of combined activation of the serotonin(1A) and \u03c3(1) receptors","volume":"809","author":"Ago","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01087_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tips.2012.10.003","article-title":"Bridging the gap: bitopic ligands of G-protein-coupled receptors","volume":"34","author":"Lane","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2026.e01087_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sbi.2020.01.003","article-title":"Nanobodies to study protein conformational states","volume":"60","author":"Ucha\u0144ski","year":"2020","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.neurot.2026.e01087_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","article-title":"Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics","volume":"22","author":"Longo","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neurot.2026.e01087_bib44","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1073\/pnas.0504016102","article-title":"Diversifying the repertoire of G protein-coupled receptors through oligomerization","volume":"102","author":"Park","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:56:52Z","timestamp":1792720612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002576"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01087","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01087"}}